Tesamorelin
Supports healthy body composition while helping preserve lean mass. A GHRH analogue studied for metabolic and body-composition goals.
Pairs with 3 recommended supplements
Tesamorelin stimulates GH to reduce visceral fat. Berberine activates AMPK, the same metabolic switch GH activates, making fat cells more responsive to the lipolytic signal Tesamorelin sends. Dual-pathway AMPK activation with robust clinical evidence for metabolic improvement that directly mirrors Tesamorelin's goals.
Visceral fat secretes inflammatory cytokines (IL-6, TNF-α) that worsen insulin resistance and blunt fat loss. Super EPA directly suppresses these signals, creating a cleaner metabolic environment for Tesamorelin's fat reduction to operate in without inflammatory resistance.
Tesamorelin's visceral fat reduction is partly driven by improved insulin sensitivity. Chromium Picolinate enhances insulin receptor sensitivity at the cellular level, directing glucose toward muscle for energy rather than fat for storage, amplifying the metabolic shift Tesamorelin drives.